AnaptysBio, Inc. revenue breakdown overview

AnaptysBio, Inc. revenue for the last year amounted to 17.16 M USD, the most of which — 17.16 M USD — came from its highest performing source at the moment, GSK - Royalty, the year earlier bringing 5.29 M USD. The greatest contribution to the revenue figure was made by United States and Australia — last year it brought AnaptysBio, Inc. 17.16 M USD, and the year before that — 10.29 M USD.